Sarah Goodpastor, MD
Internal Medicine · Durango, CONPI 1619112307
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Novo Nordisk accounts for 63.2% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $20,020, more than ten times the $1,136 reported in 2019. Among internal medicine clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 50 payments — averaging $448.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$14K
- Sanofi-aventis U.S. LLC$6K
- Medtronic$1K
- Tandem Diabetes Care, Inc.$432
- Dexcom, Inc.$318
- Insulet Corporation$258
- plus $286 from 8 others
What the payments were for
- Consulting fees$11,85453%
- Speaking & faculty fees$5,42424%
- Travel & lodging$2,71012%
- Food & beverage$2,42111%
- Education$320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 10 | $14,186 |
| Sanofi-aventis U.S. LLC | 5 | $5,557 |
| Medtronic(2 entities) | 17 | $1,404 |
| Tandem Diabetes Care, Inc. | 5 | $432 |
| Dexcom, Inc. | 3 | $318 |
| Insulet Corporation | 2 | $258 |
| Corcept Therapeutics | 1 | $144 |
| Johnson & Johnson | 1 | $31 |
| Astellas Pharma US Inc | 1 | $22 |
| Cequr Corporation | 1 | $20 |
| Philips North America LLC | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Abbott | 1 | $17 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$14,093
- TZIELD$5,424
- Minimed 670G System$962
- t:slim X2 Insulin Pump with Control-IQ$374
- Omnipod$258
- DEXCOM G7 GSS (161)$149
- Korlym$144
How this compares
$22,441 in reported general payments places this provider in the 95th percentile of 1,430 internal medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 98 | $82,497 |
| OzempicSemaglutide | 43 | $78,839 |
| TrulicityDulaglutide | 55 | $74,219 |
| MounjaroTirzepatide | 60 | $73,099 |
| JardianceEmpagliflozin | 46 | $53,872 |
| NovologInsulin Aspart | 31 | $8,841 |
| Humalog Kwikpen U-100Insulin Lispro | 16 | $3,544 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 28 | $3,385 |
| Novolog FlexpenInsulin Aspart | 12 | $1,679 |
| Gabapentin | 29 | $843 |
| Atorvastatin Calcium | 71 | $403 |
| Rosuvastatin Calcium | 31 | $350 |
| Levothyroxine Sodium | 46 | $321 |
| Tamsulosin Hcl | 15 | $307 |
| Lisinopril | 45 | $301 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $14,186 | $87,68074 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,430 internal medicine providers in Colorado.
Other internal medicine in Durango
- Gilad GordonBoulder$476K
- Kathryn PolovitzParker$403K
- Monica GrafalsAvon$401K
- Luke WebbColorado Springs$287K
- Samuel PiedadColorado Springs$154K
- Sophia AmbrusoLittleton$62K
- Kristine KuhnAurora$61K
- Kenneth OleszekDenver$60K
- Munni SelagamsettyColorado Springs$55K
- Robert KeithDenver$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.